Brokerages expect Walgreens Boots Alliance, Inc. (NASDAQ:WBA) to report earnings per share of $0.96


Analysts expect Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Get Rating) to report earnings per share of $0.96 for the current fiscal quarter, according to Zacks. Six analysts provided earnings estimates for Walgreens Boots Alliance. The highest EPS estimate is $1.10 and the lowest is $0.91. Walgreens Boots Alliance reported earnings per share of $1.51 in the same quarter last year, suggesting a negative 36.4% year-over-year growth rate. The company is due to release its next earnings report on Monday, January 1.

On average, analysts expect Walgreens Boots Alliance to report annual earnings of $5.05 per share for the current fiscal year, with EPS estimates ranging from $4.99 to $5.10. For the next fiscal year, analysts expect the company to report earnings of $4.74 per share, with EPS estimates ranging from $3.88 to $5.10. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side research analysts who provide coverage for Walgreens Boots Alliance.

Walgreens Boots Alliance (NASDAQ:WBA – Get Rating) last released quarterly earnings data on Thursday, March 31. The drugstore operator reported EPS of $1.59 for the quarter, beating consensus analyst estimates of $1.40 by $0.19. The company posted revenue of $33.76 billion in the quarter, versus a consensus estimate of $33.33 billion. Walgreens Boots Alliance achieved a return on equity of 19.15% and a net margin of 4.62%. The company’s revenue increased 3.0% year over year. In the same quarter a year earlier, the company posted earnings per share of $1.40.

WBA has been the subject of several recent analyst reports. TheStreet downgraded Walgreens Boots Alliance from a ‘b’ rating to a ‘c+’ rating in a Monday, April 4 report. Cowen lowered its price target on Walgreens Boots Alliance from $55.00 to $50.00 in a report on Tuesday. Royal Bank of Canada lowered its price target on Walgreens Boots Alliance from $52.00 to $46.00 and set an “industry performance” rating for the company in a Friday, April 1 report. Barclays lowered its price target on Walgreens Boots Alliance from $54.00 to $50.00 and set an “equal weight” rating for the company in a Friday, April 1 report. Finally, Robert W. Baird downgraded Walgreens Boots Alliance from an “outperform” rating to a “neutral” rating and reduced its price target for the stock from $70.00 to $51.00 in a report research on Friday April 1st. One research analyst has rated the stock with a sell rating and twelve have issued a hold rating for the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $50.71.

Shares of Walgreens Boots Alliance were up $0.21 during Friday trading hours, hitting $44.81. The company’s stock had a trading volume of 5,281,814 shares, compared to its average trading volume of 8,605,103. Walgreens Boots Alliance has a 12-month low of $42.90 and a 12-month high of 55. $96. The stock has a 50-day moving average of $46.62 and a 200-day moving average of $48.46. The company has a market capitalization of $38.71 billion, a PE ratio of 6.18, a growth price-earnings ratio of 2.44 and a beta of 0.55. The company has a debt ratio of 0.36, a current ratio of 0.74 and a quick ratio of 0.35.

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 11. Shareholders of record on Friday, February 18 received a dividend of $0.48. This represents a dividend of $1.92 on an annualized basis and a dividend yield of 4.28%. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.47. The ex-dividend date was Thursday, February 17. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 26.34%.

Institutional investors and hedge funds have recently increased or reduced their stake in the company. Rise Advisors LLC purchased a new stock position in Walgreens Boots Alliance during the fourth quarter for a value of approximately $27,000. Outfitter Financial LLC purchased a new stock position in Walgreens Boots Alliance during the fourth quarter for a value of approximately $31,000. City State Bank bought a new stock position in Walgreens Boots Alliance during the fourth quarter for a value of approximately $30,000. Iron Horse Wealth Management LLC increased its stake in Walgreens Boots Alliance shares by 56.0% during the first quarter. Iron Horse Wealth Management LLC now owns 635 shares of the drugstore operator worth $28,000 after purchasing an additional 228 shares during the period. Finally, West Bancorporation Inc. purchased a new stock position in Walgreens Boots Alliance during the fourth quarter worth approximately $34,000. 56.05% of the shares are held by institutional investors.

Walgreens Boots Alliance Company Profile (Get a rating)

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail business. It operates through two segments, United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumer and general merchandise through its pharmacies Retail.

See also

Get a Free Copy of Zacks Research Report on Walgreens Boots Alliance (WBA)

For more information on Zacks Investment Research’s research offerings, visit Zacks.com

Earnings history and estimates for Walgreens Boots Alliance (NASDAQ:WBA)



Get news and reviews for Walgreens Boots Alliance Daily – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for Walgreens Boots Alliance and related companies with MarketBeat.com’s free daily email newsletter.

Comments are closed.